Cargando…

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease

Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutami...

Descripción completa

Detalles Bibliográficos
Autores principales: Vader, L. Willemijn, de Ru, Arnoud, van der Wal, Yvonne, Kooy, Yvonne M.C., Benckhuijsen, Willemien, Mearin, M. Luisa, Drijfhout, Jan Wouter, van Veelen, Peter, Koning, Frits
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193762/
https://www.ncbi.nlm.nih.gov/pubmed/11877487
http://dx.doi.org/10.1084/jem.20012028
_version_ 1782147546366345216
author Vader, L. Willemijn
de Ru, Arnoud
van der Wal, Yvonne
Kooy, Yvonne M.C.
Benckhuijsen, Willemien
Mearin, M. Luisa
Drijfhout, Jan Wouter
van Veelen, Peter
Koning, Frits
author_facet Vader, L. Willemijn
de Ru, Arnoud
van der Wal, Yvonne
Kooy, Yvonne M.C.
Benckhuijsen, Willemien
Mearin, M. Luisa
Drijfhout, Jan Wouter
van Veelen, Peter
Koning, Frits
author_sort Vader, L. Willemijn
collection PubMed
description Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins.
format Text
id pubmed-2193762
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21937622008-04-14 Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease Vader, L. Willemijn de Ru, Arnoud van der Wal, Yvonne Kooy, Yvonne M.C. Benckhuijsen, Willemien Mearin, M. Luisa Drijfhout, Jan Wouter van Veelen, Peter Koning, Frits J Exp Med Brief Definitive Report Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins. The Rockefeller University Press 2002-03-04 /pmc/articles/PMC2193762/ /pubmed/11877487 http://dx.doi.org/10.1084/jem.20012028 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Vader, L. Willemijn
de Ru, Arnoud
van der Wal, Yvonne
Kooy, Yvonne M.C.
Benckhuijsen, Willemien
Mearin, M. Luisa
Drijfhout, Jan Wouter
van Veelen, Peter
Koning, Frits
Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title_full Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title_fullStr Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title_full_unstemmed Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title_short Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
title_sort specificity of tissue transglutaminase explains cereal toxicity in celiac disease
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193762/
https://www.ncbi.nlm.nih.gov/pubmed/11877487
http://dx.doi.org/10.1084/jem.20012028
work_keys_str_mv AT vaderlwillemijn specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT deruarnoud specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT vanderwalyvonne specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT kooyyvonnemc specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT benckhuijsenwillemien specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT mearinmluisa specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT drijfhoutjanwouter specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT vanveelenpeter specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease
AT koningfrits specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease